The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns

International Journal of Epidemiology

Volumn 34, Issue 3, 2005, Pages 600-609

  Jacobsen, K H ^a,b   Koopman, J S ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b CALVIN COLLEGE   (United States)

Author keywords

Hepatitis A virus; Seroprevalence studies; Socioeconomic development; Water

Indexed keywords

DRINKING WATER;

DISEASE PREVALENCE; DISEASE TRANSMISSION; GLOBAL PERSPECTIVE; HEPATITIS; SOCIOECONOMIC CONDITIONS;

ADOLESCENT; ADULT; AFRICA; AGE DISTRIBUTION; AGED; ASIA; CHILD; COMPARTMENT MODEL; CONTROLLED STUDY; DATA ANALYSIS; ECONOMIC DEVELOPMENT; EUROPE; GROUPS BY AGE; HEALTH SURVEY; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; INFECTION RATE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MIDDLE EAST; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PUBLISHING; REVIEW; SEROPREVALENCE; SOCIOECONOMICS; STATISTICAL MODEL; VIRUS TRANSMISSION; WESTERN HEMISPHERE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRINKING; ECONOMICS; HEPATITIS A; HUMAN DEVELOPMENT; HUMANS; IMMUNITY; INFANT; MIDDLE AGED; MODELS, BIOLOGICAL; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; SOCIOECONOMIC FACTORS; WATER SUPPLY;

HEPATITIS A VIRUS;

EID: 20744450116     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyi062     Document Type: Review

References (134)

1. World Health Organization. Hepatitis A vaccines. Wkly Epidemiol Rec 2000;75:38-44.
2. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999;48:1-37.
3. Jacobsen KH, Koopman JS. Changing hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect 2004; 133:1005-22.
4. Bell BP, Shapiro CN, Alter MJ et al. The diverse patterns of hepatitis A epidemiology in the United States - implications for vaccination strategies. J Infect Dis 1998;178:1579-84.
5. U.S. Bureau of the Census. International Data Base. Table 094: Midyear population by age and sex (2003).
6. Stroffolini T, Chiaramonte M, Ngatchu T et al. A high degree of exposure to hepatitis A virus infection in urban children in Cameroon. Microbiológica 1991;14:199-203.
7. Tsega E, Nordenfelt E, Mengesha B, Hansson BG, Tsega M, Lindberg J. Age-specific prevalence of hepatitis A virus antibody in Ethiopian children. Scand J Infect Dis 1990;22:145-48.
8. Barin F, Denis F, Chotard J et al. Early asymptomatic hepatitis A in Senegalese children. Lancet 1980;1:212-13.
9. Hodges M, Sanders E, Aitken C. Seroprevalence of hepatitis markers: HAV, HBV, HCV, and HEV amongst primary school children in Freetown, Sierra Leone. West Afr J Med 1998;17:36-37.
10. Abdool Karim SS, Coutsoudis A. Sero-epidemiology of hepatitis A in black South African children. S Afr Med J 1993; 83:748-49.
11. Sathar MA, Soni PN, Fernandes-Costa FJTD, Wittenberg DF, Simjee AE. Racial differences in the seroprevalence of hepatitis A virus infection in Natal/Kwazulu, South Africa. J Med Virol 1994; 44:9-12.
12. Werner GT, Frösner GG, Fresenius K. Prevalence of serological hepatitis A and B markers in a rural area of Northern Zaire. Am J Trop Med Hyg 1985;34:620-24.
13. López H, Zitto T, Baré P, Vidal G, Vukasovic J, Gómez R. Prevalence of anti-hepatitis A antibodies in an urban middle class area of Argentina: some associated factors. Int J Infect Dis 2000;4:34-37.
14. Tapia-Cónyer R, Santos JI, Cavalcanti AM et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg 1999;61:825-29.
15. Craig PG, Bryan JP, Miller RE et al. The prevalence of hepatitis A, B and C infection among different ethnic groups in Belize. Am J Trop Med Hyg 1993;49:430-34.
16. Bartoloni A, Aqauilini D, Roselli M et al. Prevalence of antibody to hepatitis A virus in the Santa Cruz region of Bolivia. J Trop Med Hyg 1989;92:279-81.
17. Bartoloni A, Bartalesi F, Roselli M et al. Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. Trop Med Int Health 1999;4:596-601.
18. Gandolfo GM, Ferri GM, Conti L et al. Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups from Santa Cruz, Bolivia. Med Clin (Barc) 2003;120:725-27.
19. Alameida LM, Werneck GL, Cairncross S, Coeli CM, Costa MCE, Coletty PE. The epidemiology of hepatitis A in Rio de Janeiro: environmental and domestic risk factors. Epidemiol Infect 2001; 107:327-33.
20. Assis SB, Souto FJD, Fontes CJF, Gaspar AMC. Prevalence of hepatitis A and E virus infection in school children of an Amazonian municipality in Mato Grosso State. Rev Soc Bras Med Trop 2002; 35:155-58.
21. Clemens SA, Fonseca JC, Azevedo T et al. Hepatitis A and hepatitis B seroprevalence in four centers in Brazil. Rev Soc Bras Med Trop 2000;33:1-10.
22. Gaze R, Carvalho DM, Werneck GL. Hepatitis A and B seroprevalence in Macae, Rio de Janeiro State, Brazil. Cad Saude Publica 2002;18:1251-59.
23. de Paula VS, Arruda ME, Vitral CL, Gaspar AMC. Seroprevalence of viral hepatitis in riverine communities from the western region of the Brazilian Amazon Basin. Mem Inst Oswaldo Cruz 2001;96: 1123-28.
24. Quieroz DA, Cardoso DD, Martelli CM et al. Risk factors and prevalence of antibodies against hepatitis A virus (HAV) in children from day-care centers in Goiania, Brazil. Rev Inst Med Trop Sao Paulo 1995;37:427-33.
25. Santos DCM, Souto FJD, Santos DRL, Vitral CL, Gaspar AMC. Seroepidemiological markers of enterically transmitted viral hepatitis A and E in individuals living in a community located in the North Area of Rio de Janeiro, RJ, Brazil. Mem Inst Oswaldo Cruz 2002; 97:637-40.
26. Vitral CL, Yoshida CFT, Lemos ERS, Teixeira CS, Gaspar AMC. Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995: relationship of prevalence to environmental factors. Mem Inst Oswaldo Cruz 1997; 93:1-5.
27. Crewe MD, Embil JA, Garner JB. Prevalence of antibodies to hepatitis A in Nova Scotia children. CMAJ 1983;128:1195-97.
28. Harb J, Lem M, Fyfe M et al. Hepatitis A in the Northern interior of British Columbia: an outbreak among members of a first nation community. Can Commun Dis Rep 1995;26:157-61.
29. Payment P. Antibody levels to selected enteric viruses in a French-Canadian population in the province of Quebec (Canada). Immunol Infect Dis 1991;1:317-22.
30. Fix AD, San Martin O, Gallicchio L, Vial PA, Lagos R. Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg 2002;66:628-32.
31. Villarejos VM, Serra CJ, Anderson-Visona K, Mosley JW. Hepatitis A virus infection in households. Am J Epidemiol 1982; 115:577-86.
32. Brown MG, Lindo JF, King SD. Investigations of the epidemiology of infections with hepatitis A virus in Jamaica. Ann Trop Med Parasitol 2000;94:497-502.
33. Kilpatrick ME, Escamilla J. Hepatitis A in Peru: the role of children. Am J Epidemiol 1986;124:111-13.
34. Montano DA, Baranano R, Legeard B et al. Prevalencia de hepatitis A en niños de 2 a 14 años y en poblacion laboral de 18 a 49 años en Montevideo, Uruguay. Rev Med Uruguay 2001;17:84-98.
35. Maynard JE, Bradley DW, Hornbeck CL, Fields RM, Doto IL, Hollinger FB. Preliminary serologic studies of antibody to hepatitis A virus in populations in the United States. J Infect Dis 1976; 134:528-30.
36. Amesty-Valbuena A, Gonzalea-Pirela Y, Rivero M. Estudio seroepidemiologico para virus de hepatitis A en niños de Maracaibo, Venezuela. Invest Clin 1989;30:215-28.
37. Boughton CR, Hawkes RA, Ferguson V. Viral hepatitis A and B: a sero-epidemiologic study of a non-hepatitic Sydney population. Med J Aust 1980;1:177-80.
38. Lehmann NI, Gust ID. Prevalence of antibody to hepatitis A virus in two populations in Victoria, Australia. Med J Aust 1977; 2:731-32.
39. Geng J, Xu D, Gong J, Li W. Assessing hepatitis A virus epidemic stochastic process in eight cities in China in 1990. Int J Epidemiol 1998;27:320-22.
40. Chin KP, Lok ASF, Wong LSK, Lai CL, Wu PC. Current seroepidemiology of hepatitis A in Hong Kong. J Med Virol 1991; 34:191-93.
41. Acharya SK, Batra Y, Bhatkal B et al. Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol 2003;18:822-27.
42. Arankalle VA, Tsarev SA, Chadha MS et al. Age-specific prevalence of antibodies to hepatitis A and E viruses in Pune, India, 1982 and 1992. J Infect Dis 1995;171:447-50.
43. Arankalle VA, Chadha MS, Chitambar SD, Walimbe AM, Chobe LP, Gandhe SS. Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-1998). J Viral Hepat 2001;8:293-303.
44. Batra Y, Bhatkal B, Ojha B et al. Vaccination against hepatitis A virus may not be required for schoolchildren in northern India: results of a seroepidemiological survey. Bull World Health Organ 2002;80:728-31.
45. Corwin AL, Putri MP, Winarno J et al. Epidemic and sporadic hepatitis E virus transmission: West Kalimantan (Borneo), Indonesia. Am J Trop Med Hyg 1997;57:62-65.
46. Juffrie M, Graham RR, Tan RI et al. Seroprevalence of hepatitis A virus and varicella zoster antibodies in Javanese community (Yogyakarta, Indonesia). Southeast Asian J Trop Med Public Health 2000;31:21-24.
47. Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan, over a 26-year period. Am J Trop Med Hyg 1998;59:693-98.
48. Ichida F, Suzuki S, Furuta S et al. Age specific prevalence of anti HA in Japan: from multi-institutional analysis. Gastroenterol Jpn 1981;16:384-88.
49. Ikematsu H, Kashiwagi S, Hayashi J et al. A seroepidemiologic study of hepatitis A virus infections: statistical analysis of two independent cross-sectional surveys in Okinawa, Japan. Am J Epidemiol 1987;126:50-54.
50. Kashiwagi S, Hayashi J, Ikematsu H et al. Prevalence of antibody to hepatitis A virus in Okinawa and Kyushu, Japan. Am J Epidemiol 1983;117:55-59.
51. Kiyohara T, Satoh T, Yamamoto H, Totsuka A, Moritsugu Y. The latest seroepidemiological pattern of hepatitis A in Japan. Jpn J Med Sci Biol 1997;50:123-31.
52. Sohn YM, Rho HO, Park MS et al. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei Med J 2000;41:34-39.
53. Tan DSK, Fang R, Collett D, Ooi BG. Seroepidemiologic study of hepatitis A in Malaysia. Southeast Asian J Trop Med Public Health 1986;17:201-04.
54. Sawayama Y, Hayashi J, Ariyama I et al. A ten year serological survey of hepatitis A, B and C viruses infections in Nepal. J Epidemiol 1999;9:350-54.
55. Goh KT, Wong LY, Oon CJ, Kumarapathy S. The prevalence of antibody to hepatitis A in Singapore. Asia Pac J Public Health 1987; 1:9-11.
56. Vitarana T, Kanapathipillai M, Gunasekera HDN, Lehmann NI, Dimitrikakis M, Gust ID. A seroepidemiological study of hepatitis A and hepatitis B infection in Sri Lanka. Asian J Infect Dis 1978; 2:247-52.
57. Wu JS, Chen CH, Chiang YH et al. Seroepidemiology of hepatitis A infection in children in Taiwan. J Formos Med Assoc 1980; 79:694-99.
58. Burke DS, Snitbhan R, Johnson DE, Scott R McN. Age specific prevalence of hepatitis A virus antibody in Thailand. Am J Epidemiol 1981;113:245-49.
59. Kalayanarooj S, Vaughn DW, Snitbhan R, Ariyasriwatana C. Age-specific prevalence of hepatitis A antibody in Thai children. Southeast Asian J Trop Med Public Health 1995;26:709-11.
60. Poovorawan Y, Paiboonkasemsuthi S, Theamboonlers A, Kamolratanakul P, Chumdermpadetsuk S. Seroepidemiology of antibody to hepatitis A in the rural eastern part of Thailand. Southeast Asian J Trop Med Public Health 1991;22:35-38.
61. Viranuvatti V, Hemindra P, Chainuvati T. Anti-HAV in Thai population. J Med Assoc Thai 1982;65:379-82.
62. Hau CH, Hien TT, Tien NT et al. Prevalence of enteric hepatitis A and E viruses in the Mekong River delta region of Vietnam. Am J Trop Med Hyg 1999;60:277-80.
63. Prodinger WM, Larcher C, Solder BM, Geissler D, Dietrich MP. Hepatitis A in western Austria: the epidemiologic situation before the introduction of active immunisation. Infection 1994; 22:53-55.
64. Vranckx R, Muylle L. Hepatitis A virus antibodies in Belgium: relationship between prevalence and age. Infection 1990; 18:364-66.
65. Beran J, Douda P, Rychly R. Seroprevalence of viral hepatitis A in the Czech Republic. Eur J Epidemiol 1999;15:805-08.
66. Linneberg A, Østergaard C, Tvede M et al. IgG antibodies against microorganisms and atopic disease in Danish adults: the Copenhagen Allergy Study. J Allergy Clin Immunol 2003; 111:847-53.
67. Frösner GG, Papaevangelou G, Bütler R et al. Antibody against hepatitis A in seven European countries. I: Comparison of prevalence data in different age groups. Am J Epidemiol 1979; 110:63-69.
68. Frösner G, Willers H, Müller R, Schenzle D, Deinhardt F, Höpken W. Decrease in incidence of hepatitis A infections in Germany. Infection 1978;6:259-60.
69. Thierfelder W, Hellenbrand W, Meisel H, Schreier E, Dortschy R. Prevalence of markers for hepatitis A, B and C in the German population: results of the German National Health Interview and Examination Survey 1998. Eur J Epidemiol 2001;17:429-35.
70. Kremastinou J, Kalapothaki V, Trichopoulos D. The changing epidermiologic pattern of hepatitis A infection in urban Greece. Am J Epidemiol 1984;120:703-06.
71. Papaevangelou G. Epidemiology of hepatitis A in Mediterranean countries. Vaccine 1992;10:S63-66.
72. Langer BCA, Frösner GG, von Brunn A. Epidemiological study of viral hepatitis types A, B, C, D and E among Inuits in West Greenland. J Viral Hepat 1997;4:339-49.
73. Briem H. Declining prevalence of antibodies to hepatitis A virus infection in Iceland. Scand J Infect Dis 1991; 23:135-38.
74. Briem H, Weiland O, Frioriksson I, Berg R. Prevalence of antibody to hepatitis A in Iceland in relation to age, sex, and number of notified cases of hepatitis. Am J Epidemiol 1982; 116:451-55.
75. Chiaramonte M, Floreani A, Silvan C et al. Hepatitis A and hepatitis B virus infection in children and adolescents in North-East Italy. J Med Virol 1983;12:179-86.
76. Chiaramonte M, Moschen ME, Stroffolini T et al. Changing epidemiology of hepatitis A virus (HAV) infection: a comparative seroepidemiological study (1979 vs 1989) in north-east Italy. Ital J Gastroenterol 1991;23:344-46.
77. D'Argenio P, Esposito D, Mele A et al. Decline in the exposure to hepatitis A and B virus infection in children in Naples, Italy. Public Health 1989;103:385-89.
78. La Rosa G, Guli V, Terrana B. First results of anti HAV antibodies assay in Western Sicily. Boll Ist Sieroterapico Milan 1978;57:682-83.
79. Moschen ME, Floreani A, Zamparo E et al. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol 1997;13:875-78.
80. Stroffolini T, Franco E, Romano G et al. Hepatitis A virus infection in children in Sardinia, Italy. Community Med 1989;11:336-41.
81. Stroffolini T, Chiaramonte M, Franco E et al. Baseline seroepidemiology of hepatitis A virus infection among children and teenagers in Italy. Infection 1991;19:97-100.
82. Stroffolini T, De Crescenzo L, Giammanco A et al. Changing pattern of hepatitis A infection in children in Palermo, Italy. Eur J Epidemiol 1990;6:84-87.
83. Zanetti AR, Ferroni P, Bastia A. Decline in incidence of hepatitis A infection in Milan: a serologic study. Boll Ist Sieroterapico Milan 1978;57:816-20.
84. Zanetti AR, Romano L, Tanzi E et al. Decline in anti-HAV prevalence in the Milan area between 1958-1992. Eur J Epidemiol 1994;10:633-35.
85. Termorshuizen F, Dorigo-Zetsma JW, de Melker HE, van den Hof S, Conyn-Van Spaendonck MAE. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infect 2000;134:459-66.
86. Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000;18:S68-70.
87. Polz-Dacewicz MA, Policzkiewicz P, Badach Z. Changing epidemiology of hepatitis A virus infection: a comparative study in Central Eastern Poland (1990-1999). Med Sci Monit 2000; 6:989-93.
88. Barros H, Oliveira F, Miranda H. A survey on hepatitis A in Portuguese children and adolescents. J Viral Hepat 1999; 6:249-53.
89. Lecour H, Ribeiro AT, Amaral I, Rodrigues MA. Prevalence of viral hepatitis in the population of Portugal. Bull World Health Organ 1984;62:743-47.
90. Stroffolini T, Pretolani S, Miglio F et al. Population-based survey of hepatitis A virus infection in the Republic of San Marino. Eur J Epidemiol 1997;13:687-89.
91. Amela C, Pachón I, Bueno R, de Miguel C, Martinez-Navarro F. Trends in hepatitis A virus infection with reference to the process of urbanization in the greater Madrid area (Spain). Eur J Epidemol 1995;11:569-73.
92. Bolumar F, Giner-Duran R, Hernandez-Aguado I, Serra-Desfilis MA, Rebagliato M, Rodrigo JM. Epidemiology of hepatitis A in Valencia, Spain: public health implications. J Viral Hepat 1995; 2:145-49.
93. Bruguera M, Salleras L, Plans P et al. Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996: implications for new vaccination strategy. Med Clin (Barc) 1999;112:406-08.
94. Cilla G, Perez-Trallero E, Marimon JM, Erdozain S, Gutierrez C. Prevalence of hepatitis A antibody among disadvantaged gypsy children in northern Spain. Epidemiol Infect 1995;115:157-61.
95. Dal-Ré R, García-Corbeira P, García-de-Lomas J. A large percentage of the Spanish population under 30 years of age is not protected against hepatitis A. J Med Virol 2000;6:363-66.
96. Garcia-Fulgueiras A, Rodriguez T, Tormo MJ, Perez-Flores D, Chirlaque D, Navarro C. Prevalence of hepatitis A antibodies in southeastern Spain: a population-based study. Eur J Epidemiol 1997;13:481-83.
97. González A, Bruguera M, Calbo Torrecillas F, Monge V, Dal-Ré R, Costa J. Encuestra seroepidemiologica de prevalencia de anticuerpos antihepatitis A en la poblacion adulta joven Española. Med Clin (Barc) 1994;103:445-48.
98. Montes I, Agulla A. Prevalencia de marcadores de hepatitis viricas en niños del norte de Extremadura. An Pediatr (Barc) 1996; 45:133-36.
99. Perez-Trallero E, Cilla G, Urbieta M, Dorronsoro M, Otero F, Marimon JM. Falling incidence and prevalence of hepatitis A in northern Spain. Scand J Infect Dis 1994;26:133-36.
100. Rodriguez-Iglesias MA, Perez-Garcia MT, Garcia-Valdivia MS, Perez-Ramos S. Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain. Infection 1995; 23:309.
101. Salleras L, Bruguera M, Vidal J et al. A change in the epidemiologic pattern of hepatitis A in Spain. Med Clin (Barc) 1992;99:87-89.
102. Vargas V, Buti M, Hernandez-Sanchez JM, Jardi R, Portell A, Esteban R, Guardia J. Prevalencia de los anticuerpos contra el virus de la hepatitis A en la poblacion general: studio comparative 1977-85. Med Clin (Barc) 1987;88:144-46.
103. Böttiger M, Christenson B, Grillner L. Hepatitis A immunity in the Swedish population: a study of the prevalence of markers in the Swedish population. Scand J Infect Dis 1997; 29:99-102.
104. Iwarson S, Frösner G, Lindholm A, Norkrans G. The changed epidemiology of hepatitis A infection in Scandinavia. Scand J Infect Dis 1978;10:155-56.
105. Weiland O, Berg R, Böttiger M, Lundberge P. Prevalence of antibody against hepatitis A in Sweden in relation to age and type of community. Scand J Infect Dis 1980;12:171-74.
106. Damjanovic V, Ross M, Brumfitt W. Studies on antibody to hepatitis A virus in children and adults in London. Infection 1979;7:267-72.
107. Gay NJ, Morgan-Capner P, Wright J, Farrington CP, Miller E. Age-specific antibody prevalence to hepatitis A in England: implications for disease control. Epidemiol Infect 1994;113:113-20.
108. Morris MC, Gay NJ, Hesketh LM, Morgan-Capner P, Miller E. The changing epidemiological pattern of hepatitis A in England and Wales. Epidemiol Infect 2002;128:457-63.
109. Khalfa S, Ardjoun H. Epidemiologie des hepatitis virales en Algerie. Med Trop (Mars) 1984;44:247-52.
110. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian populations: a viral marker study. Ann Acad Med Singap 1980;9:144-48.
111. Chironna M, Germinario C, Lopalco PL, Carrozzini F, Barbuti S, Quarto M. Prevalence rates of viral hepatitis infections in refugee Kurds from Iraq and Turkey. Infection 2003;31:70-74.
112. Shamma'a MH, Abu-Samra S, Salameh V, Nassar NT. The significance of anti-HAV in different population sectors in Lebanon: a comparative seroepidemiologic study. Int J Epidemiol 1982; 11:406-09.
113. Nejmi S, Coursaget P, D'Khissy D, Barres JL, Chiron P. Prévalence des infections par les virus des hépatitis A et B au Maroc. Presse Med 1984;13:1786-87.
114. Agboatwalla M, Isomura S, Miyake K, Yamashita T, Morishita T, Akram DS. Hepatitis A, B and C seroprevalence in Pakistan. Indian J Pediatr 1994;61:545-49.
115. El-Hamzi MAF. Hepatitis A antibodies: prevalence in Saudi Arabia. J Trop Med Hyg 1989;92:427-30.
116. Khalil M, Al-Mazrou Y, Al-Jeffri M, Al-Howasi M. Childhood epidemiology of hepatitis A virus in Riyadh, Saudi Arabia. Ann Saudi Med 1998;18:18-21.
117. Ramia S. Antibody against hepatitis A in Saudi Arabians and in expatriates from various parts of the world working in Saudi Arabia. J Inject 1986;12:153-55.
118. Shobokshi O, Serebour F, Abdul-Rahim SM. The prevalence and pattern of hepatitis A viral infection in the western region of Saudi Arabia. Saudi Med J 1986;7:402-08.
119. Tufenkeji H. Hepatitis A shifting epidemiology in the Middle East and Africa. Vaccine 2000;18:S65-67.
120. Antaki N, Kamel Kebbewar M. Hepatitis A seroprevalence rate in Syria. Trop Doct 2000;30:99-101.
121. Baki A, Aynaci M, Koksal I. Prevalence of antibody to hepatitis A virus among children in Trabzon, Turkey. Infection 1993;21: 132-33.
122. Kanra G, Tezcan S, Badur S. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002; 44:204-10.
123. Sidal M, Unuvar E, Oguz F, Cihan C, Onel D, Badur S. Age-specific seroepidemiology of hepatitis A, B, and E infections among children in Istanbul, Turkey. Eur J Epidemiol 2001; 17:141-44.
124. Yapicioglu H, Alhan E, Yildizdas D, Yaman A, Bozdemir N. Prevalence of hepatitis A in children and adolescents in Adana, Turkey. Indian Pediatr 2002;39:936-41.
125. WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. Global Water Supply and Sanitation Assessment 2000 Report.
126. United Nations Development Programme. Human Development Report 2003. Available at: http://hdr.undp.org/reports/global/2003/indicator/index_indicators.html.
127. World Bank. GNI per capita 2002. World Development Indicators Database, July 2003.
128. Schenzle D, Dietz K, Frösner GG. Antibody against hepatitis A in seven European countries: statistical analysis of cross-sectional surveys. Am J Epidemiol 1979;110:70-76.
129. Hu M, Schenzle D, Deinhardt F, Scheid R. Epidemiology of hepatitis A and B in the Shanghai area: prevalence of serum markers. Am J Epidemiol 1984;120:404-14.
130. Struchiner CJ, Alameida LM, Azevedo RS, Massad E. Hepatitis A incidence rate estimates from a pilot seroprevalence survey in Rio de Janeiro, Brazil. Int J Epidemiol 1999;28:776-81.
131. Alameida LM, Amaku M, Azevedo RS, Cairncross S, Massad E. The intensity of transmission of hepatitis A and heterogeneities in socio-environmental risk factors in Rio de Janeiro, Brazil. Trans R Soc Trop Med Hyg 2002;96:605-10.
132. Gay NJ. A model of long-term decline in the transmissibility of an infectious disease: implications for the incidence of hepatitis A. Int J Epidemiol 1996;25:854-61.
133. Farrington CP, Kanaan MN, Gay NJ. Estimation of the basic reproduction number for infectious diseases from age-stratified serological survey data. Appl Stat 2001;50:251-92.
134. Poorvorawan Y, Vimolkej T, Chongsrisawat V, Theamboonlers A, Chumdermpadetsuk S. The declining pattern of seroepidemiology of hepatitis A virus infection among adolescents in Bangkok, Thailand. Southeast Asian J Trop Med Public Health 1997;28:154-57.